Our Mission

Everyone has a story about cancer. Our mission is to rewrite how cancer is detected and treated.

TransCode Therapeutics is leading the way in bringing RNA therapies to oncology. Created on the belief that through the intelligent design and effective delivery to formerly undruggable RNA targets, TransCode is pioneering the development of therapeutics and diagostics to significantly improve patient outcomes.

Until now, RNA technology has been locked behind the challenge of delivery -- getting the RNA into the right cells and to their internal targets.

​TransCode believes it has overcome this barrier, opening the door to RNA therapy and applying it to cancer -- a disease with the highest unmet need that affects everyone. It is through the design and optimization of this technology that TransCode has devised an elegant solution -- TTX -- a proprietary delivery vehicle for the transport of RNA therapeutics to targeted cancer cells. With their world class team and know how, TransCode has a rapidly expanding platform of drug candidates designed to target a variety of tumor types.

Learn more about the Science behind TTX and about our Pipeline.

TransCode is delivering on the promise of successfully bringing RNA to oncology patients everywhere. Writing a new cancer story starts here.